MIR4777: A Potential Drug Target and Biomarker (G100616317)

MIR4777: A Potential Drug Target and Biomarker

MIR4777, also known as interleukin-4777, is a protein that is expressed in various tissues throughout the body. It is a member of the Interleukin-4 family, which includes other proteins such as IL-1, IL-2, and IL-12. MIR4777 has been shown to play a role in various biological processes, including immune response, inflammation, and tissue repair. As a result, MIR4777 has potential as a drug target and biomarker.

The discovery and characterization of MIR4777 began in the late 1990s, when researchers identified it as a differentially expressed gene in a variety of tissues, including muscle, pancreas, and skin. The gene was later named MIR4777 due to its location on the chromosome, specifically, position 4777.

Since its discovery, MIR4777 has been shown to be involved in numerous biological processes, including:

1. Immune Response: MIR4777 has been shown to play a role in the immune response by regulating the production of T cells. T cells are a crucial part of the immune system, responsible for detecting and destroying foreign substances in the body. MIR4777 has been shown to prevent the suppression of T cell proliferation, which is critical for the immune response.
2. Inflammation: MIR4777 has been shown to contribute to inflammation by regulating the production of pro-inflammatory cytokines. Pro-inflammatory cytokines, such as TNF-alpha, IL-1, and IL-6, are important drivers of inflammation in the body. MIR4777 has been shown to prevent the production of these cytokines, which can help to reduce inflammation.
3. Tissue Repair: MIR4777 has been shown to play a role in tissue repair by regulating the production of fibroblasts. Fibroblasts are cells that produce collagen, a protein that is important for tissue repair and regeneration. MIR4777 has been shown to prevent the production of fibroblasts, which can help to promote tissue repair.

In addition to its role in immune response, inflammation, and tissue repair, MIR4777 has also been shown to have potential as a drug target. For example, researchers have found that MIR4777 is a good candidate for a drug that targets the immune response. This is because MIR4777 is involved in regulating T cell proliferation and has been shown to prevent the suppression of T cells, which is important for the immune response.

Another potential use for MIR4777 as a drug target is its role in cancer. Researchers have found that MIR4777 is often expressed in various types of cancer, including breast, ovarian, and prostate cancer. This suggests that MIR4777 may be a useful biomarker for cancer and could potentially serve as a target for new cancer therapies.

MIR4777 has also been shown to be involved in various signaling pathways in the body. For example, MIR4777 has been shown to be involved in the PI3K/Akt signaling pathway. This pathway is important for cell signaling and has been implicated in a variety of biological processes, including cancer growth and metastasis.

In conclusion, MIR4777 is a protein that has been shown to play a role in various biological processes, including immune response, inflammation, and tissue repair. Its potential as a drug target and biomarker makes it an attractive target for new therapies. Further research is needed to fully understand the role of MIR4777 in these processes and to develop new treatments.

Protein Name: MicroRNA 4777

The "MIR4777 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4777 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR4778 | MIR4779 | MIR4780 | MIR4781 | MIR4782 | MIR4783 | MIR4784 | MIR4785 | MIR4786 | MIR4787 | MIR4789 | MIR4790 | MIR4791 | MIR4793 | MIR4794 | MIR4795 | MIR4796 | MIR4797 | MIR4798 | MIR4799 | MIR4800 | MIR4802 | MIR4803 | MIR4804 | MIR483 | MIR484 | MIR485 | MIR486-1 | MIR486-2 | MIR487A | MIR487B | MIR488 | MIR489 | MIR490 | MIR491 | MIR492 | MIR493 | MIR494 | MIR495 | MIR496 | MIR497 | MIR497HG | MIR498 | MIR4999 | MIR499A | MIR499B | MIR5000 | MIR5001 | MIR5002 | MIR5003 | MIR5004 | MIR5006 | MIR5007 | MIR5008 | MIR5009 | MIR500A | MIR500B | MIR501 | MIR5010 | MIR5011 | MIR502 | MIR503 | MIR503HG | MIR504 | MIR5047 | MIR505 | MIR506 | MIR507 | MIR508 | MIR5088 | MIR5089 | MIR509-1 | MIR509-2 | MIR509-3 | MIR5090 | MIR5091 | MIR5092 | MIR5093 | MIR5094 | MIR510 | MIR5100 | MIR511 | MIR511-2 | MIR512-1 | MIR512-2 | MIR513A1 | MIR513A2 | MIR513B | MIR513C | MIR514A1 | MIR514A2 | MIR514A3 | MIR514B | MIR515-1 | MIR515-2 | MIR516A1 | MIR516A2 | MIR516B1 | MIR516B2 | MIR517A